Xenetic Biosciences, Inc. (XBIO) is a publicly traded Healthcare sector company. As of June 1, 2026, XBIO trades at $3.10 with a market cap of $7.22M and a P/E ratio of -1.98. XBIO moved +0.00% today. Year to date, XBIO is +45.16%; over the trailing twelve months it is +5.70%. Its 52-week range spans $1.90 to $13.93. Rallies surfaces XBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Xenetic Biosciences, Inc. (XBIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XBIO moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $3.10 |
| Market Cap | $7.22M |
| P/E Ratio | -1.98 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.93 |
| 52-Week Low | $1.90 |
| Volume | 7.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.98M |
| Net Income | $-2.68M |
| Gross Margin | 0.00% |
XBIO analyst coverage data. Average price target: $0.00.